A Yeast Cell Wall Derived Hybrid Hydrogel with Photothermal and Immune Combined Modality Therapy for Enhanced Anti-Melanoma Efficacy
Chen Yang,Jiaxing Lei,Ximeng Kang,Peipei Zhang,Shaohua Zheng,Qingqing Li,Jiye Zhang
DOI: https://doi.org/10.2147/ijn.s409674
IF: 7.033
2023-09-21
International Journal of Nanomedicine
Abstract:Chen Yang, 1 Jiaxing Lei, 1 Ximeng Kang, 1 Peipei Zhang, 1 Shaohua Zheng, 2 Qingqing Li, 1 Jiye Zhang 1 1 School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China; 2 The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China Correspondence: Qingqing Li; Jiye Zhang, School of Pharmacy, Health Science Center, Xi'an Jiaotong University, No. 76 Yanta Westroad, Xi'an, People's Republic of China, Email ; Introduction: The effect of traditional treatment for melanoma is quite limited, especially for its recurrence. As the major components of yeast cell wall, chitin and β-glucan exhibit good immune activation effect and are promising candidates for adjuvant. Therefore, melanoma cell membrane (CM) and indocyanine green (ICG) was loaded in a chitin and β-glucan hybrid hydrogel to achieve an enhanced anti-melanoma therapy. Methods: The novel hybrid hydrogel was prepared, and its physicochemical properties were examined. Its effect towards melanoma prevention and treatment was evaluated via a melanoma-bearing mice model. Results: The CM-ICG-hybrid hydrogel was successfully prepared with excellent injectability, self-healing, drug loading, rheological, in vitro and in vivo photothermal stability, and retention properties. It also exhibited good cellular and in vivo safety profiles. In the primary melanoma mice model, it quickly ablated the in-situ melanoma, effectively inhibited the tumor growth, increased the survival rate of melanoma-bearing mice, and increased the level of IFN-γ and TNF-α. In the distal secondary melanoma model, it efficiently prevented the reoccurrence of melanoma and activated the memory T cells. In both models, a synergistic effect of photothermal therapy and immune therapy was found. The hydrogel effectively recruited CD3 + CD4 + T cells and CD3 + CD8 + T cells, inhibited the proliferation of melanoma cells, and induced the apoptosis of melanoma cells. Conclusion: The hybrid hydrogel was successfully prepared, and it showed excellent efficacy towards melanoma prevention and treatment due to its efficient tumor ablation and immune activation capability. Graphical Keywords: chitin, β-glucan, hybrid hydrogel, melanoma cell membrane, photo thermotherapy, immunotherapy Graphical Melanoma, generally referred to as malignant melanoma, is derived from the malignant transformation of nerves and melanocytes in skin. 1 It is the most aggressive skin cancer. 1,2 Except for the difficulty in diagnosis, melanoma also has high risk of metastasis and recurrence, poor prognosis, and low five-year survival rate. 2,3 At present, surgical resection is still the most popular treatment for melanoma. 4,5 However, due to its limited surgery scope, its effects for advanced melanoma and melanoma with lymph node metastasis are poor. 4,6,7 Chemotherapy is commonly accompanied with strong side effects and high risk of tumor resistance and tumor metastasis. 3–5 Radiation therapy also elicits strong side effects, immunosuppression, and tumor metastasis. 1,4,8,9 Photothermal therapy (PTT) can rapidly ablate most in-situ tumors due to the high targeting effect, small wound surface, and low side effects. Shao et al reported that a black phosphorus quantum dots-PLGA nanosphere-based PTT showed good biocompatibility as well as excellent PTT efficiency and breast tumor ablation effect. There was no recurrence during the observation period. 10 Heidari et al used indocyanine green (ICG) and gold-ferrite nanocomposite as photothermal agents, and the tumors of mice could also be ablated after PTT. 11 Indocyanine green is an FDA-approved near-infrared dye. 12–14 It is also a photosensitizer with high photothermal conversion efficiency. 12 When the temperature of the tumor exceeds 45°C, protein starts to denature and the cell membrane begins to rupture, which leads to immunogenic cell death. 13–15 However, photothermal therapy is not effective for advanced complex diffuse tumors, metastases, and recurrent tumors. 13,15–17 Immunotherapy is a novel potential method of tumor treatment. 18,19 A large number of monoclonal antibodies based on immune checkpoint inhibitors have been approved and launched on the market. For example, the approved anti-PD-1 antibodies nebuliumab and pabolizumab are effective in patients with BRAF mutations and BRAF inhibitor refractory diseases. 20 Talimogene laherparepvec (T-VEC) replicates within tumor cells and produces granulocyte -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology